When does the label say to call your doctor?
From the Patient Information leaflet that comes with Avodart:
- Swelling of the face, tongue or throat, or serious skin reactions such as peeling: get medical help right away.
- Breast lumps or nipple discharge: talk to your healthcare provider.
- Any rise in PSA on treatment, even within the normal range, is evaluated by your healthcare provider.
What are the most common Avodart side effects?
These are the label's own numbers from the Adverse Reactions section. Where the label compares with placebo (a dummy treatment), both columns are shown, so you can see how much more often a reaction happened on Avodart.
| Adverse Reaction | Months 0‑6 | Months 7‑12 | Months 13‑18 | Months 19‑24 |
|---|---|---|---|---|
| Impotence: Avodart | 4.7% | 1.4% | 1.0% | 0.8% |
| Impotence: Placebo | 1.7% | 1.5% | 0.5% | 0.9% |
| Decreased libido: Avodart | 3.0% | 0.7% | 0.3% | 0.3% |
| Decreased libido: Placebo | 1.4% | 0.6% | 0.2% | 0.1% |
| Ejaculation disorders: Avodart | 1.4% | 0.5% | 0.5% | 0.1% |
| Ejaculation disorders: Placebo | 0.5% | 0.3% | 0.1% | 0.0% |
| Breast disorders: Avodart | 0.5% | 0.8% | 1.1% | 0.6% |
| Breast disorders: Placebo | 0.2% | 0.3% | 0.3% | 0.1% |
Men with BPH aged 47 to 94 on Avodart 0.5 mg daily or placebo. Columns are when the reaction first started; n falls over time (Avodart 2,167 / 1,901 / 1,725 / 1,605; placebo 2,158 / 1,922 / 1,714 / 1,555). The label says the sexual reactions are linked to dutasteride and may persist after stopping; the role of dutasteride in that is unknown. Breast disorders include breast tenderness and enlargement.
Other numbers in the Adverse Reactions section
- Section 6.14% of men on Avodart and 3% on placebo left the placebo-controlled trials because of side effects, most often impotence (1%).
- Section 6.1With tamsulosin (CombAT trial), ejaculation disorders were 11% on the combination vs 2% on Avodart alone and 4% on tamsulosin alone. In the first 6 months: ejaculation disorders 7.8% vs 1.0% vs 2.2%, impotence 5.4% vs 4.0% vs 2.6%, decreased libido 4.5% vs 3.1% vs 2.0%.
Show 3 more findingsShow fewer
- Section 6.1Heart failure (composite term) after 4 years: 0.7% on the combination vs 0.1% on Avodart and 0.6% on tamsulosin; 0.6% vs 0.4% on placebo in the REDUCE trial. The label says most had other heart risk factors and no causal link has been established.
- Section 5.1Avodart lowers PSA by about 50% within 3 to 6 months of treatment.
- Section 6.2Reported after approval: allergic reactions including rash, itching, hives, localized swelling, serious skin reactions and angioedema; male breast cancer; depressed mood; and testicular pain and swelling.
What serious risks does the Avodart label warn about?
The Warnings and Precautions part of the label lists these. Each line gives the label's heading and what it means in plain words.
- Section 5.1Lower PSA readings. Avodart cuts PSA by about half within 3 to 6 months. A new PSA baseline is set at least 3 months after starting, and any confirmed rise from the lowest value may signal prostate cancer and is evaluated, even if it is in the normal range. Missed doses can also affect PSA results.
- Section 5.2High-grade prostate cancer. In a 4-year trial of men 50 to 75, Gleason 8-10 prostate cancer was 1.0% on Avodart vs 0.5% on placebo. 5 alpha-reductase inhibitors may raise the risk of high-grade prostate cancer.
- Section 5.3Other urological conditions. Other conditions that cause similar symptoms are considered before starting, and BPH and prostate cancer may exist together.
- Section 5.4Risk to a male fetus. Women who are or may be pregnant should not handle Avodart capsules, because dutasteride can be absorbed through the skin. Skin contact with a leaking capsule is washed right away with soap and water.
Show 3 more risksShow fewer
- Section 5.5Blood donation. Men on Avodart should not donate blood until at least 6 months after the last dose, so it does not reach a pregnant transfusion recipient.
- Section 5.6Semen changes. Over 52 weeks, Avodart lowered total sperm count, semen volume and sperm motility compared with placebo; the drop in sperm count had not reversed 24 weeks after stopping. Values stayed in the normal range, and the effect on fertility is not known.
- Section 4Who should not use it. Pregnant women, and anyone with a past clinically significant allergic reaction (such as serious skin reactions or angioedema) to Avodart or another 5 alpha-reductase inhibitor.
Does Avodart have a boxed warning?
No. The current Avodart label has no boxed warning.
How do I keep track of side effects in Dose Track?
Dose Track has a side-effect log. Each entry records the symptom, a severity (none, mild, moderate, severe or life-threatening), the date and an optional note, and can be tied to a specific dose or logged on its own.
Read moreRead less
The history screen shows what you logged over time, which makes it easier to tell your prescriber when a reaction started and whether it is easing. The app records what you enter; it does not judge whether a symptom is serious. For anything on the label's call-your-doctor list, call your doctor.
Frequently asked questions
What is the most common side effect of Avodart?
Impotence. In the first 6 months of the placebo-controlled BPH trials it was 4.7% on Avodart vs 1.7% on placebo, falling to 0.8% vs 0.9% for new cases in months 19 to 24 (section 6.1, Table 1).
Do Avodart sexual side effects go away?
New cases became less frequent after the first 6 months. The label says impotence, decreased libido and ejaculation problems may persist after stopping, and the role of dutasteride in that is unknown (section 6.1).
Does Avodart affect fertility?
Over 52 weeks it lowered total sperm count, semen volume and sperm motility versus placebo, and the sperm count drop had not reversed 24 weeks later. Values stayed in the normal range; the effect on fertility is not known (section 5.6).
Can you donate blood while taking Avodart?
No. The label says men should not donate blood until at least 6 months after their last dose, to keep dutasteride from reaching a pregnant transfusion recipient (section 5.5).
Does Avodart have a boxed warning?
No. The current Avodart label has no boxed warning. Its warnings cover PSA changes, high-grade prostate cancer, risk to a male fetus, blood donation and semen changes (sections 5.1 to 5.6).
Related pages
- Avodart dosing schedule from the same label
- Dutasteride compound guide
- Missed a dose of Avodart? What the label says
- Free reconstitution calculator
Show similar medicinesShow fewer
Side effects for similar medicines
See also
- Finasteride vs dutasteride: how do Propecia and Avodart differ?
- When does dutasteride peak and reach steady state?
- How to store Avodart (dutasteride)
- Nuvigil side effects
- Provigil side effects
Track it in Dose Track: GLP-1 tracker, TRT tracker or peptide tracker.
Sources
- AVODART (dutasteride) capsules, for oral use, prescribing information and Patient Information. Waylis Therapeutics. DailyMed, version published March 17, 2025. DailyMed setid 960797b3-09b1-4d6a-8ece-8b5d918e93e4
What Avodart is approved forHide
Avodart is a 5 alpha-reductase inhibitor approved to treat symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate, alone or with tamsulosin: to improve symptoms and lower the risk of acute urinary retention and BPH-related surgery. It is not approved to prevent prostate cancer, and it is not approved for hair loss (section 1).
This page is what the FDA label says, in plain words. It is not medical advice. Follow your prescriber, and ask them or your pharmacist about anything here.
All side-effect pages · Dosing schedules · Missed dose guides · Compound guides